ADiTx Therapeutics DSO Ratio 2011-2026 | ADTX

Annual DSO Ratio ADiTx Therapeutics

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
621	116	17.6	156	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
621	17.6	227

Quarterly DSO Ratio ADiTx Therapeutics

2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
10.8 K	10.8 K	-	5.05 K	859	478	-	272	146	179	-	152	140	73.5	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
10.8 K	73.5	2.63 K

DSO Ratio of other stocks in the Biotechnology industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Acorda Therapeutics ACOR	48.3	-	-24.86 %	$ 820 K	USA
AgeX Therapeutics AGE	78.4	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	0.114	-	-	$ 26.5 M	USA
AbCellera Biologics ABCL	173	$ 3.55	-2.18 %	$ 1.06 B	Canada
I-Mab IMAB	271	-	-	$ 866 M	China
ADMA Biologics ADMA	74.6	$ 15.66	-5.32 %	$ 3.73 B	USA
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
Aptorum Group Limited APM	20.6	$ 0.82	-0.73 %	$ 4.47 M	China
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
Alpine Immune Sciences ALPN	154	-	-	$ 2.17 B	USA
Apellis Pharmaceuticals APLS	115	$ 20.16	1.51 %	$ 2.54 B	USA
ANI Pharmaceuticals ANIP	114	$ 75.5	-1.35 %	$ 1.46 B	USA
Aravive ARAV	16.8	-	-13.39 %	$ 1.45 M	USA
Adverum Biotechnologies ADVM	222	-	-	$ 86.2 M	USA
Athersys ATHX	22.6	-	3.77 %	$ 22.4 M	USA
Corcept Therapeutics Incorporated CORT	27.3	$ 34.35	-3.75 %	$ 3.57 B	USA
Corbus Pharmaceuticals Holdings CRBP	239	$ 7.8	-7.36 %	$ 33.8 M	USA
CorMedix CRMD	127	$ 6.32	-11.24 %	$ 322 M	USA
AVEO Pharmaceuticals AVEO	47.5	-	-	$ 521 M	USA
Champions Oncology CSBR	66.5	$ 5.79	-3.58 %	$ 79.1 M	USA
Axsome Therapeutics AXSM	105	$ 160.44	-2.22 %	$ 7.98 B	USA
BridgeBio Pharma BBIO	52.4	$ 65.38	-1.74 %	$ 12.5 B	USA
Denali Therapeutics DNLI	1.89	$ 19.69	-3.34 %	$ 3.24 B	USA
BioDelivery Sciences International BDSI	115	-	-4.8 %	$ 255 M	USA
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
BeiGene, Ltd. BGNE	52.6	-	0.49 %	$ 251 B	Cayman-islands
Edesa Biotech EDSA	97.1	$ 3.8	-10.9 %	$ 12.2 M	USA
Equillium EQ	33.2	$ 1.79	2.0 %	$ 62.2 M	USA
Bellicum Pharmaceuticals BLCM	6.09	-	-9.72 %	$ 5.89 M	USA
Berkeley Lights BLI	103	-	-7.31 %	$ 87 M	USA
CureVac N.V. CVAC	13.6	-	-	$ 867 M	Germany
Aeterna Zentaris AEZS	146	-	5.93 %	$ 314 M	Canada
BioMarin Pharmaceutical BMRN	88.9	$ 60.47	0.07 %	$ 11.6 B	USA
Eton Pharmaceuticals ETON	30.4	$ 17.04	-2.77 %	$ 437 M	USA